What is the treatment for a patient with antidromic atrioventricular reentrant tachycardia (AVRT)?

Treatment of Antidromic AVRT

For antidromic AVRT, avoid AV nodal blocking agents (adenosine, verapamil, diltiazem) and instead use procainamide or ibutilide for hemodynamically stable patients, or immediate synchronized cardioversion for unstable patients. 1

Critical Distinction from Orthodromic AVRT

Antidromic AVRT is fundamentally different from orthodromic AVRT because the accessory pathway conducts antegradely (atria to ventricles) while the AV node conducts retrogradely, creating a wide-complex tachycardia that mimics ventricular tachycardia. 2, 3 This occurs in less than 5-10% of patients with WPW syndrome. 2

Acute Management Algorithm

For Hemodynamically Unstable Patients:

• Immediate synchronized cardioversion is the definitive first-line treatment without attempting pharmacologic therapy. 1
• Do not delay cardioversion for drug preparation if the patient demonstrates hypotension, altered mental status, signs of shock, acute heart failure, or ongoing chest pain. 4

For Hemodynamically Stable Patients:

• Ibutilide or intravenous procainamide are the recommended first-line agents (Class I, Level B-R). 1
• These agents work by prolonging the refractory period of the accessory pathway, which is the antegrade limb of the circuit in antidromic AVRT. 5
• Synchronized cardioversion should be performed if pharmacologic therapy fails or is contraindicated. 1

Critical Contraindications

Never use AV nodal blocking agents in antidromic AVRT:

• Adenosine, verapamil, diltiazem, and digoxin are contraindicated because they block the AV node (the retrograde limb) but do not affect the accessory pathway (the antegrade limb). 5
• These agents may paradoxically enhance conduction down the accessory pathway, potentially increasing ventricular rate or precipitating ventricular fibrillation. 5
• This is the same principle that applies to pre-excited atrial fibrillation—the accessory pathway must be targeted, not the AV node. 1

Distinguishing Antidromic AVRT from VT

The wide-complex tachycardia of antidromic AVRT is frequently misdiagnosed as ventricular tachycardia:

• Antidromic AVRT presents as a regular wide-complex tachycardia with a QRS duration often >170 milliseconds due to ventricular activation via the accessory pathway. 2
• The baseline ECG may show pre-excitation (delta waves) if the pathway conducts during sinus rhythm, helping identify WPW syndrome. 3
• However, some accessory pathways are concealed or latent, showing no pre-excitation at baseline, making diagnosis more challenging. 3, 6
• Adenosine can be diagnostic (terminating orthodromic AVRT or AVNRT) but should be used cautiously as it may precipitate atrial fibrillation with rapid ventricular response via the accessory pathway. 1, 7

Definitive Management

• Catheter ablation is the treatment of choice for patients with symptomatic antidromic AVRT and should be considered after acute stabilization. 2, 3
• Ablation success rates are high, though anteroseptal and septal pathways near the His bundle pose technical challenges and may require cryoablation rather than radiofrequency ablation to avoid AV block. 2
• The prognostic significance of inducible antidromic AVRT during electrophysiology study remains controversial, though it may indicate higher risk in pediatric populations. 2

Common Pitfalls

• Misdiagnosing antidromic AVRT as VT and treating with amiodarone or other agents that don't address the accessory pathway. 2, 6
• Using AV nodal blockers (the most dangerous error), which can worsen the arrhythmia or precipitate life-threatening rhythms. 5
• Failing to recognize pre-excited atrial fibrillation, which requires the same treatment approach as antidromic AVRT (procainamide/ibutilide or cardioversion, never AV nodal blockers). 1